EUVIMEDEUVIMED entdecken
Crossref

Neuropeptide Y regulates myocardial fibrosis via NPY1R/JAK2/STAT3 signaling pathway

Wei Huang, Yuehua Chen, Yan Chen, Dongliang Li, Yanqiu Zhang, Junli Guo

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.118372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Wei Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of basic medical sciences, Hainan Academy of Medical Sciences,Hain…. Hauptthemen laut MEDLINE: Neuropeptide Y, Janus Kinase 2, STAT3 Transcription Factor, Receptors, Neuropeptide Y. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Hainan Medical University, Natural Science Foundation of Hainan Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The level of neuropeptide Y (NPY) is elevated during the pathological progression of heart failure (HF). However, the role and molecular mechanisms of NPY in cardiac fibrosis remain largely uninvestigated. NPY levels were found to be elevated in the serum and fibrotic rat heart tissues after myocardial infarction (MI). Whole-body knock-out NPY (NPY-KO) in rats ameliorated cardiac fibrosis, endothelial mesenchymal transition (EndMT) and cardiac dysfunction and reduced infarct size after myocardial infarction. In contrast, treatment with NPY in rats promoted cardiac fibrosis, EndMT and cardiac dysfunction. Additionally, NPY small interfering RNA (siRNA) in neonatal rat cardiac fibroblasts (CFs) and human coronary artery endothelial cells (HCAECs) reduced fibroblast activation and EndMT in response to TGF-β1 stimulation, while NPY, when given separately, increased fibrotic responses and EndMT-like changes. Bioinformatics and proteome analysis showed that JAK2 (Janus Kinase 2) was mediated by NPY. Further investigation revealed that NPY significantly elevated the expression of NPY receptor Y1 (NPY1R), phosphorylated JAK2 (p-JAK2) and phosphorylated STAT3 (p-STAT3). NPY1R antagonist (BIBO3304) and JAK2/STAT3 inhibitor (WP1066) alleviated cardiac dysfunction, reduced cardiac fibrosis and mitigated EndMT-like changes in rats after NPY administration. Similarly, NPY promoted cell proliferation, collagen production, and EndMT in CFs and HCAECs, whereas BIBO3304 and WP1066 inhibited fibroblast activation and EndMT-like changes induced by NPY. These findings indicate that NPY drives cardiac fibrosis and cardiac dysfunction may be associated with the activation of the NPY1R/JAK2/STAT3 axis, making it a promising therapeutic target to suppress the progression of fibrotic responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuropeptide YJanus Kinase 2STAT3 Transcription FactorReceptors, Neuropeptide YMyocardiumAnimalsSignal TransductionFibrosisRatsMaleHumansRats, Sprague-DawleyCells, CulturedMyocardial InfarctionReceptors, NeuropeptideReceptors, G-Protein-Coupled

Stichwörter der Autor:innen

CardiacfibrosisEndMTJAK2NPY1RNeuropeptide Y

Substanzen

Neuropeptide YJanus Kinase 2STAT3 Transcription FactorJak2 protein, ratReceptors, Neuropeptide YNpy1r protein, ratStat3 protein, ratReceptors, NeuropeptideReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of basic medical sciences, Hainan Academy of Medical Sciences,Hainan Medical University, Haikou 571199, China; Key Laboratory of Tropica…
  • The College of Medical Laboratory Science and Technology, Harbin Medical University (Daqing), Daqing 163319, China.
  • Department of Pharmacology, Harbin Medical University (Daqing), Daqing 163319, China. Electronic address: zhangyanqiu@hrbmu.edu.cn.
  • Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory for Tropical Cardiovascular Diseases Research, School of Public Health, The First Affiliated Hospital, Hainan…

Förderung

  • Hainan Medical University
  • Natural Science Foundation of Hainan Province
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Huang, W., Chen, Y., Chen, Y., Li, D., Zhang, Y., & Guo, J. (2026). Neuropeptide Y regulates myocardial fibrosis via NPY1R/JAK2/STAT3 signaling pathway. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118372

Vancouver

Huang W, Chen Y, Chen Y, Li D, Zhang Y, Guo J. Neuropeptide Y regulates myocardial fibrosis via NPY1R/JAK2/STAT3 signaling pathway. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118372

BibTeX
@article{Huang2026,
  author = {Huang, Wei and Chen, Yuehua and Chen, Yan and Li, Dongliang and Zhang, Yanqiu and Guo, Junli},
  title = {Neuropeptide Y regulates myocardial fibrosis via NPY1R/JAK2/STAT3 signaling pathway},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.118372}
}
Kostenlos starten →